This study is looking at whether a medication called Methylprednisolone (Medrol Dose Pack) can help people who have headaches after a concussion (Post-Concussion Syndrome). Researchers want to see if this medicine can reduce how often or how bad these headaches are, and if it can help with other symptoms like dizziness, allowing people to return to daily activities sooner. The study plans to enroll 25 adults, aged 18 and older, who are able to take oral medication. Success will be measured by changes in headache symptoms after one week. The current recruitment status is unclear.

Study design

This is an observational study with a planned enrollment of 25 participants. It is not specified if it is a randomized or blinded study.

What's involved

Participants will take the Methylprednisolone dose pack, which is tapered over 7 days. The study will measure changes in headaches at 1 week.

Compensation

Not stated in the trial record.

Follow-up

Headaches will be measured at 1 week after starting the medication.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.